Illumina Ventures alumnus Noel Lee has moved up to partner at Novo Holdings, just eight months after being hired as a principal in its Growth Investments team.

Claire Leurent, formerly principal at Johnson & Johnson Innovation – JJDC, has joined AbbVie’s CVC unit as managing director.

Payments is an area fintech investors we've spoken to see as ripe for a shake up. They're also watching for an AI crash and the direction of interest rates.

Dalton ran Pfizer Ventures during a period when pharmaceutical companies shifted to greater dependence on CVC to access innovation.

MOL Plus, Maersk Growth and IMC Ventures will maintain the investment pace next year while exploring ways to further transform the industry.

The fund, co-managed with a seed-stage VC firm, will target AI, robotics and internet-of-things across multiple industries.

Co-founder Marcelo Claure is returning to lead the newly independent Open Opportunity Fund with Paul Judge, while SoftBank invests in its $200m second fund.

It is no surprise to see genAI on this list, but semiconductors, EVs, green steel and batteries also featured heavily this year.

GCV Powerlist mainstay and corporate VC veteran Lisa Lambert has taken up a new role at the charitable organisation as chief investment officer.

Alphabet’s early-stage investment unit has hired Michael McBride to seek out AI and open-source software startups.